Even so, certain tumors have a significant and independent propensity to express high TIM‐3 transcript levels, including pancreatic cancer and tumors with high PD‐L1 and/or high CTLA‐4 transcript levels. This evidence concerns the gene CTLA4 and familial pancreatic carcinoma.